latest-news-headlines Market Intelligence /marketintelligence/en/news-insights/latest-news-headlines/wedgewood-pharmacy-220m-term-loan-for-buyout-allocates-rises-on-break-terms-62848831 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Wedgewood Pharmacy $220M term loan for buyout allocates, rises on break; terms

Blog

Tracking Credit Risk at a Major U.S. Retailer

Blog

M&A rebound sparks optimism for near-term deal activity

Blog

What's on the Horizon for the Cruise Hotel Resorts Sector

Capital Markets View – February 2021


Wedgewood Pharmacy $220M term loan for buyout allocates, rises on break; terms

Investors today received allocations of Wedgewood Village Pharmacy Inc.'s $220 million seven-year covenant-lite term loan B that priced tight of talk via joint bookrunners Macquarie and Natixis, according to sources. Pricing was finalized at L+450 with a 0.75% Libor floor and an issue price of 99. The loan broke for trading in a 99.375/99.875 market, before ticking up to 99.625/100.125. The deal backs Partners Group's acquisition of Wedgewood from New Harbor Capital. Financing also includes a $40 million, five-year revolver with a springing first-lien leverage covenant.

Wedgewood Pharmacy provides compounded animal medications for acute and chronic conditions.

Terms:

Borrower Wedgewood Pharmacy
Issue $220 million term loan B
UoP LBO
Spread L+450
Libor floor 0.75%
Price 99
Tenor 7-year
YTM 5.54%
Four-year yield 5.65%
Call protection 101 soft call for 6 months
Corporate ratings B-/B3
Facility ratings B-/B3
Recovery ratings 3
Financial covenants None
Arrangers Macq/Natx
Admin agent Macq
Px Talk L+475-500/0.75%/99
Sponsor Partners Group
Notes